This finding not only uncovers the potential molecular mechanism underlying the miR-372-3p inhibition of colon cancer cell growth by targeting MAP3K2 but also opens up a new approach for the development of a therapeutic strategy for colon cancer. This evidence concerns the gene MAP3K2 and colonic neoplasm.